{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:47:10Z","timestamp":1784947630207,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.dld.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T02:17:23Z","timestamp":1443233843000},"page":"162-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Protective effects of tranilast on oxazolone-induced rat colitis through a mast cell-dependent pathway"],"prefix":"10.1016","volume":"48","author":[{"given":"Hong-Qian","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Dong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Tao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2015.09.002_bib0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2015.09.002_bib0220","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nature Protocols"},{"key":"10.1016\/j.dld.2015.09.002_bib0225","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1084\/jem.188.10.1929","article-title":"Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4","volume":"188","author":"Boirivant","year":"1998","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.dld.2015.09.002_bib0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1078\/0065-1281-00641","article-title":"Mast cells and inflammatory mediators in chronic ulcerative colitis","volume":"104","author":"Stoyanova","year":"2002","journal-title":"Acta Histochemica"},{"key":"10.1016\/j.dld.2015.09.002_bib0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molimm.2012.09.007","article-title":"3,3\u2019-Diindolylmethane alleviates oxazolone-induced colitis through Th2\/Th17 suppression and Treg induction","volume":"53","author":"Huang","year":"2013","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.dld.2015.09.002_bib0240","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2478\/v10039-012-0029-3","article-title":"Mast cells and eosinophils are involved in activation of ulcerative colitis","volume":"57","author":"Stasikowska-Kanicka","year":"2012","journal-title":"Advances in Medical Sciences"},{"key":"10.1016\/j.dld.2015.09.002_bib0245","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.dld.2015.09.002_bib0250","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2036.2008.03624.x","article-title":"Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease \u2013 clinical relevance and pathophysiological mechanisms","volume":"27","author":"De Schepper","year":"2008","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.09.002_bib0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2982.2005.00685.x","article-title":"Functional gastrointestinal disorders and mast cells: implications for therapy","volume":"18","author":"Barbara","year":"2006","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.dld.2015.09.002_bib0260","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/003655201750065933","article-title":"Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease","volume":"36","author":"Raithel","year":"2001","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.09.002_bib0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1113\/jphysiol.2006.123158","article-title":"Increased responsiveness of rat colonic splanchnic afferents to 5-HT after inflammation and recovery","volume":"579","author":"Coldwell","year":"2007","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.dld.2015.09.002_bib0270","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00011-006-6017-y","article-title":"Long-term study of TNBS-induced colitis in rats: focus on mast cells","volume":"55","author":"Menozzi","year":"2006","journal-title":"Inflammation Research"},{"key":"10.1016\/j.dld.2015.09.002_bib0275","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3748\/wjg.v10.i3.309","article-title":"Key role of mast cells and their major secretory products in inflammatory bowel disease","volume":"10","author":"He","year":"2004","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.09.002_bib0280","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/gut.33.11.1498","article-title":"Ketotifen effectively prevents mucosal damage in experimental colitis","volume":"33","author":"Eliakim","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.09.002_bib0285","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2036.2002.01194.x","article-title":"Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study","volume":"16","author":"Tremaine","year":"2002","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2015.09.002_bib0290","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jps.22299","article-title":"Development of inhalable nanocrystalline solid dispersion of tranilast for airway inflammatory diseases","volume":"100","author":"Onoue","year":"2011","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.dld.2015.09.002_bib0295","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/oxfordjournals.jbchem.a124612","article-title":"Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts","volume":"116","author":"Yamada","year":"1994","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.dld.2015.09.002_bib0300","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-2952(87)90353-4","article-title":"Selective inhibition of collagen accumulation by N-(3,4-dimethoxycinnamoyl)anthranilic acid (N-5\u2019) in granulation tissue","volume":"36","author":"Isaji","year":"1987","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.dld.2015.09.002_bib0305","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/02770900903089998","article-title":"Effects of tranilast and pentoxifylline in a mouse model of chronic asthma using house dust mite antigen","volume":"46","author":"Kim","year":"2009","journal-title":"Journal of Asthma"},{"key":"10.1016\/j.dld.2015.09.002_bib0310","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpb.2010.11.005","article-title":"Stable dry powder inhaler formulation of tranilast attenuated antigen-evoked airway inflammation in rats","volume":"77","author":"Kawabata","year":"2011","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.dld.2015.09.002_bib0315","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1476-5381.2009.00561.x","article-title":"The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice","volume":"159","author":"Shiota","year":"2010","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.dld.2015.09.002_bib0320","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1440-1827.2009.02490.x","article-title":"Rectal administration of tranilast ameliorated acute colitis in mice through increased expression of heme oxygenase-1","volume":"60","author":"Sun","year":"2010","journal-title":"Pathology International"},{"key":"10.1016\/j.dld.2015.09.002_bib0325","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3748\/wjg.15.1821","article-title":"Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats","volume":"15","author":"Zhang","year":"2009","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.09.002_bib0330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/00365529850166914","article-title":"Oxazolone-induced colitis in rats: effects of budesonide, cyclosporin a, and 5-aminosalicylic acid","volume":"33","author":"Ekstrom","year":"1998","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.09.002_bib0335","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.105.088146","article-title":"Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats","volume":"315","author":"Lamprecht","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.dld.2015.09.002_bib0340","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.dld.2011.08.030","article-title":"Opposite effects of substance P and calcitonin gene-related peptide in oxazolone colitis","volume":"44","author":"Engel","year":"2012","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2015.09.002_bib0345","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/003655200750024380","article-title":"Plasma exudation, hyperaemia, and epithelial permeability in rats with oxazolone-induced colitis: modulatory effects of budesonide","volume":"35","author":"Ekstrom","year":"2000","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.09.002_bib0350","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.52.5.713","article-title":"Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats","volume":"52","author":"Kihara","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2015.09.002_bib0355","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1423-0127-20-76","article-title":"Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro","volume":"20","author":"Darakhshan","year":"2013","journal-title":"Journal of Biomedical Science"},{"key":"10.1016\/j.dld.2015.09.002_bib0360","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.7150\/ijbs.4679","article-title":"Interleukin-6, a major cytokine in the central nervous system","volume":"8","author":"Erta","year":"2012","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.dld.2015.09.002_bib0365","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.0801217","article-title":"Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6\/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model","volume":"184","author":"Matsumoto","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.dld.2015.09.002_bib0370","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.dld.2015.09.002_bib0375","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"Neurath","year":"2011","journal-title":"Cytokine and Growth Factor Reviews"},{"key":"10.1016\/j.dld.2015.09.002_bib0380","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3748\/wjg.v16.i18.2252","article-title":"Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis","volume":"16","author":"Wang","year":"2010","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.09.002_bib0385","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2013.03.033","article-title":"Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3","volume":"132","author":"Junttila","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.dld.2015.09.002_bib0390","doi-asserted-by":"crossref","first-page":"e11944","DOI":"10.1371\/journal.pone.0011944","article-title":"IL-33 is produced by mast cells and regulates IgE-dependent inflammation","volume":"5","author":"Hsu","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2015.09.002_bib0395","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","article-title":"Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis","volume":"45","author":"Kobori","year":"2010","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2015.09.002_bib0400","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.0801898105","article-title":"IL-33 exacerbates antigen-induced arthritis by activating mast cells","volume":"105","author":"Xu","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.dld.2015.09.002_bib0405","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as tunable effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.dld.2015.09.002_bib0410","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.4049\/jimmunol.180.4.2443","article-title":"IL-33, a potent inducer of adaptive immunity to intestinal nematodes","volume":"180","author":"Humphreys","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.dld.2015.09.002_bib0415","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1189\/jlb.0407200","article-title":"IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals","volume":"82","author":"Ho","year":"2007","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.dld.2015.09.002_bib0420","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2011.09.044","article-title":"B cells that produce immunoglobulin E mediate colitis in BALB\/c mice","volume":"142","author":"Hoving","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815006155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815006155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:31:00Z","timestamp":1567211460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865815006155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1590865815006155"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2015.09.002","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of tranilast on oxazolone-induced rat colitis through a mast cell-dependent pathway","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}